Metabolic effects of telmisartan in subjects with abdominal obesity: A prospective randomized controlled trial

Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes: The TRANSCEND study

(2011) J. I. Barzilay et al.   DIABETES CARE

Telmisartan improves insulin sensitivity: A meta-analysis of randomized head-to-head trials

(2011) Hisato Takagi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Effects of Telmisartan Therapy on Metabolic Profiles and Serum High Molecular Weight (HMW)-Adiponectin Level in Japanese Male Hypertensive Subjects with Abdominal Obesity

(2011) Naoko Komiya et al.   Journal of Atherosclerosis and Thrombosis

Telmisartan Effects on Insulin Resistance in Obese or Overweight Adults Without Diabetes or Hypertension

(2010) Willa Hsueh et al.   Journal of Clinical Hypertension

Comparative Effects of Telmisartan and Eprosartan on Insulin Sensitivity in the Treatment of Overweight Hypertensive Patients

(2009) R. Fogari et al.   HORMONE AND METABOLIC RESEARCH

Effects of telmisartan on adiponectin levels and body weight in hypertensive patients with glucose intolerance

(2008) Shinji Makita et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T

(2007) Xiaojuan Li et al.   MAGNETIC RESONANCE IMAGING

Protection of pancreatic beta-cells: Is it feasible?

(2007) Enzo Bonora   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES